T. Rowe Price Investment Management, Inc. Ionis Pharmaceuticals Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 16,048,721 shares of IONS stock, worth $661 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
16,048,721
Previous 16,175,533
0.78%
Holding current value
$661 Million
Previous $488 Million
29.93%
% of portfolio
0.4%
Previous 0.32%
Shares
12 transactions
Others Institutions Holding IONS
# of Institutions
413Shares Held
149MCall Options Held
1.73MPut Options Held
729K-
Vanguard Group Inc Valley Forge, PA16.7MShares$688 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA12.5MShares$516 Million0.08% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$425 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.85MShares$323 Million7.06% of portfolio
-
Wellington Management Group LLP Boston, MA6.35MShares$261 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.85B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...